Cefoxitin: Difference between revisions
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
Cefoxitin is a second-generation cephamycin antibiotic developed by Merck & Co., Inc. from Cephamycin C in the year following its discovery, 1972. See also [https://en.wikipedia.org/wiki/Cefoxitin Cefoxitin]. | Cefoxitin is a second-generation cephamycin antibiotic developed by Merck & Co., Inc. from Cephamycin C in the year following its discovery, 1972. See also [https://en.wikipedia.org/wiki/Cefoxitin Cefoxitin]. | ||
[[7kcx]]. | <scene name='10/1040131/Cv/2'>S. aureus penicillin-binding protein 4 (PBP4) in complex with cefoxitin</scene> [[7kcx]]. | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||